Amneal Goes After ProAir, Lumigan And Diprivan With Latest Filings
Fresh ANDA Filings With FDA Reflect Firm’s Increasing Move Into Complex Generics
With a continuing focus on complex generics, Amneal has revealed a trio of US filings targeting ProAir, Lumigan and Diprivan.